Company profile: Iota Sciences
1.1 - Company Overview
Company description
- Provider of cell biology discovery technologies, including a Cloning Platform that gently handles single cells and uses less culture medium to produce verified clonal cultures, a scPicking Platform utilizing low-volume cell chambers to isolate single cells for transfer to downstream formats, and hiPSC gene-editing services.
Products and services
- Cloning Platform: Architects a single-cell system that handles cells gently and uses less culture medium to yield verified clonal cultures, enhancing consistency and cutting waste
- HiPSC Gene-Editing Services: Delivers hiPSC-specific gene-editing services for human-induced pluripotent stem cells (hiPSCs) to advance discovery in cell biology
- ScPicking Platform: Engineers a low-volume cell-chamber platform to isolate single cells, which can be transferred into various downstream formats
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Iota Sciences
Scienion
HQ: Germany
Website
- Description: Provider of ultra-low volume liquid handling systems and microarray technologies enabling multiparallel bioanalytics, high throughput screening, and high throughput microarray production in genomics. Offerings include automated dispensers (sciFLEXARRAYER), pico- to microliter non-contact printing (sciDROP PICO), single-cell isolation (CellenONE), functionalized slides (sciCHIPs), buffers (sciBUFFERs), and consumables.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scienion company profile →
SQZ Biotech
HQ: United States
Website
- Description: Provider of cell engineering technology designed to deliver a diverse set of materials into patient cells and to develop cellular therapies for multiple indications using proprietary CellSqueeze technology, advanced through internal research programs and external partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SQZ Biotech company profile →
Pepscan
HQ: The Netherlands
Website
- Description: Provider of peptide R&D and production services, employing protein mimicry techniques and patented technologies. Offerings include peptide libraries, CLIPS technology, personalized neoantigen peptide pools, epitope mapping, and custom peptide synthesis with modifications, plus phage display and lead optimization at an end-to-end facility in Lelystad, the Netherlands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pepscan company profile →
ViaCord
HQ: United States
Website
- Description: Provider of women's health biotechnology services, including ViaCord for preserving newborn umbilical cord blood, cord tissue banking, and ViaCyte for cryopreservation of unfertilized eggs, plus newborn genomic offerings such as DNA preservation, celiac and lactose risk testing, a panel analyzing over 270 genes, and whole genome sequencing of 22,000 genes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ViaCord company profile →
ABclonal
HQ: China
Website
- Description: Provider of global antibody and molecular enzyme reagents, offering antibodies for research and diagnostic applications; proteins, peptides, ELISA kits to detect and quantify proteins and other molecules; molecular biology reagents; and next-generation sequencing products and services for genetic analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ABclonal company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Iota Sciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Iota Sciences
2.2 - Growth funds investing in similar companies to Iota Sciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Iota Sciences
4.2 - Public trading comparable groups for Iota Sciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →